Shu M - Search Results

1

miR-221/222 suppression induced by activation of the cAMP/PKA/CREB1 pathway is required for cAMP-induced bidirectional differentiation of glioma cells.

Liu Q, Tian R, Yu P, Shu M. Liu Q, et al. Among authors: shu m. FEBS Lett. 2021 Nov;595(22):2829-2843. doi: 10.1002/1873-3468.14208. Epub 2021 Oct 27. FEBS Lett. 2021. PMID: 34687039 Free article.

2

Hypoxia-inducible factor-1alpha blocks differentiation of malignant gliomas.

Lu H, Li Y, Shu M, Tang J, Huang Y, Zhou Y, Liang Y, Yan G. Lu H, et al. Among authors: shu m. FEBS J. 2009 Dec;276(24):7291-304. doi: 10.1111/j.1742-4658.2009.07441.x. FEBS J. 2009. PMID: 19912340 Free article.

3

MicroRNA 335 is required for differentiation of malignant glioma cells induced by activation of cAMP/protein kinase A pathway.

Shu M, Zhou Y, Zhu W, Zhang H, Wu S, Chen J, Yan G. Shu M, et al. Mol Pharmacol. 2012 Mar;81(3):292-8. doi: 10.1124/mol.111.076166. Epub 2011 Dec 15. Mol Pharmacol. 2012. PMID: 22172575

4

Identification and Validation of an Immune-Associated RNA-Binding Proteins Signature to Predict Clinical Outcomes and Therapeutic Responses in Glioma Patients.

Tian R, Li Y, Liu Q, Shu M. Tian R, et al. Among authors: shu m. Cancers (Basel). 2021 Apr 6;13(7):1730. doi: 10.3390/cancers13071730. Cancers (Basel). 2021. PMID: 33917399 Free PMC article.

5

Hypoxia blocks ferroptosis of hepatocellular carcinoma via suppression of METTL14 triggered YTHDF2-dependent silencing of SLC7A11.

Fan Z, Yang G, Zhang W, Liu Q, Liu G, Liu P, Xu L, Wang J, Yan Z, Han H, Liu R, Shu M. Fan Z, et al. Among authors: shu m. J Cell Mol Med. 2021 Nov;25(21):10197-10212. doi: 10.1111/jcmm.16957. Epub 2021 Oct 5. J Cell Mol Med. 2021. PMID: 34609072 Free PMC article.

6

Circadian Regulation Patterns With Distinct Immune Landscapes in Gliomas Aid in the Development of a Risk Model to Predict Prognosis and Therapeutic Response.

Tian R, Li Y, Shu M. Tian R, et al. Among authors: shu m. Front Immunol. 2022 Jan 6;12:797450. doi: 10.3389/fimmu.2021.797450. eCollection 2021. Front Immunol. 2022. PMID: 35069579 Free PMC article.

7

Therapeutic targeting m6A-guided miR-146a-5p signaling contributes to the melittin-induced selective suppression of bladder cancer.

Yan R, Dai W, Wu R, Huang H, Shu M. Yan R, et al. Among authors: shu m. Cancer Lett. 2022 May 28;534:215615. doi: 10.1016/j.canlet.2022.215615. Epub 2022 Mar 9. Cancer Lett. 2022. PMID: 35278613

8

Overcoming therapeutic resistance in oncolytic herpes virotherapy by targeting IGF2BP3-induced NETosis in malignant glioma.

Dai W, Tian R, Yu L, Bian S, Chen Y, Yin B, Luan Y, Chen S, Fan Z, Yan R, Pan X, Hou Y, Li R, Chen J, Shu M. Dai W, et al. Among authors: shu m. Nat Commun. 2024 Jan 2;15(1):131. doi: 10.1038/s41467-023-44576-2. Nat Commun. 2024. PMID: 38167409 Free PMC article.

9

NSUN5/TET2-directed chromatin-associated RNA modification of 5-methylcytosine to 5-hydroxymethylcytosine governs glioma immune evasion.

Wu R, Sun C, Chen X, Yang R, Luan Y, Zhao X, Yu P, Luo R, Hou Y, Tian R, Bian S, Li Y, Dong Y, Liu Q, Dai W, Fan Z, Yan R, Pan B, Feng S, Wu J, Chen F, Yang C, Wang H, Dai H, Shu M. Wu R, et al. Among authors: shu m. Proc Natl Acad Sci U S A. 2024 Apr 2;121(14):e2321611121. doi: 10.1073/pnas.2321611121. Epub 2024 Mar 28. Proc Natl Acad Sci U S A. 2024. PMID: 38547058 Free PMC article.

10

Anesthetic pentobarbital inhibits proliferation and migration of malignant glioma cells.

Xie J, Li Y, Huang Y, Qiu P, Shu M, Zhu W, Ou Y, Yan G. Xie J, et al. Among authors: shu m. Cancer Lett. 2009 Sep 8;282(1):35-42. doi: 10.1016/j.canlet.2009.02.055. Epub 2009 Apr 5. Cancer Lett. 2009. PMID: 19346066

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

871 results

Search Page

Filters